Skip to main content

Westrock Coffee Co

For the period ended Sep 30, 2024. Filed Nov 7, 2024.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2024 · Filed Nov 7, 2024

WEST$8.79-2.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Key Business Metrics

We use Consolidated Adjusted EBITDA to evaluate our performance, identify trends, formulate financial projections, and to make strategic decisions.

Consolidated Adjusted EBITDA

We refer to EBITDA and Consolidated Adjusted EBITDA in our analysis of our results of operations, which are not required by, or presented in accordance with, accounting principles generally accepted in the United States (“GAAP”). While we believe that net (loss) income, as defined by GAAP, is the most appropriate earnings measure, we also believe that EBITDA and Consolidated Adjusted EBITDA are important non-GAAP supplemental measures of operating performance as they contribute to a meaningful evaluation of the Company’s future operating performance and comparisons to the Company’s past operating performance. The Company believes that providing these non-GAAP

financial measures helps investors evaluate the Company’s operating performance, profitability and business trends in a way that is consistent with how management evaluates such performance.

We define “EBITDA” as net (loss) income, as defined by GAAP, before interest expense, provision for income taxes and depreciation and amortization. We define “Consolidated Adjusted EBITDA” as EBITDA before equity-based compensation expense and the impact, which may be recurring in nature, of transaction, restructuring and integration related costs, including management services and consulting agreements entered into in connection with the acquisition of S&D Coffee, Inc., impairment charges, changes in the fair value of warrant liabilities, non-cash mark-to-market adjustments, certain non-capitalizable costs necessary to place the Conway extract and ready-to-drink facility into commercial production, the write off of unamortized deferred financing costs, costs incurred as a result of the early repayment of debt, gains or losses on dispositions, and other similar or infrequent items (although we may not have had such charges in the periods presented). We believe EBITDA and Consolidated Adjusted EBITDA are important supplemental measures to net (loss) income because they provide additional information to evaluate our operating performance on an unleveraged basis.

Since EBITDA and Consolidated Adjusted EBITDA are not measures calculated in accordance with GAAP, they should be viewed in addition to, and not be considered as alternatives for, net (loss) income determined in accordance with GAAP. Further, our computations of EBITDA and Consolidated Adjusted EBITDA may not be comparable to that reported by other companies that define EBITDA and Consolidated Adjusted EBITDA differently than we do.

The reconciliation of our net (loss) income to EBITDA and Consolidated Adjusted EBITDA for the three and nine months ended September 30, 2024 and 2023 is as follows:

​​​​​​​​​​​​​
​ · ​ · Three Months Ended September 30, · Nine Months Ended September 30,
(Thousands) · 2024 · 2023 · 2024 · 2023
Net (loss) income​$(14,259)​$16,621​$(55,691)​$(14,516)
Interest expense​6,889​7,803​21,921​21,216
Income tax expense (benefit)​84​(5,212)​1,254​(3,331)
Depreciation and amortization​7,680​6,364​23,196​18,419
EBITDA​394​25,576​(9,320)​21,788
Transaction, restructuring and integration expense​2,538​3,137​9,901​12,682
Change in fair value of warrant liabilities​​(5,481)​​(25,105)​​(7,134)​​(18,833)
Management and consulting fees (S&D Coffee, Inc. acquisition)​—​—​—​556
Equity-based compensation​3,028​2,439​8,508​6,297
Impairment charges​​1,165​​—​​1,996​​—
Conway extract and ready-to-drink facility pre-production costs​​7,937​​3,035​​30,115​​6,615
Mark-to-market adjustments​470​1,160​(2,692)​(1,045)
Loss on disposal of property, plant and equipment​(8)​248​965​1,145
Other​226​1,105​1,506​2,153
Consolidated Adjusted EBITDA​$10,269​$11,595​$33,845​$31,358

The Company presents Consolidated Adjusted EBITDA as excluding certain Conway extract and ready-to-drink facility start-up costs (“Conway Start-up Costs”). Prior to the third quarter of 2024, Conway Start-up Costs included two categories: (i) non-capitalizable costs necessary to place production and packaging capabilities into commercial production (“pre-production costs”), and (ii) recurring operating costs incurred once a capability is placed into commercial production but before completion of the production scale up (“scale up operating costs”). Beginning in the third quarter of 2024, the Company no longer excludes scale up operating costs in the determination of Consolidated Adjusted EBITDA. Consolidated Adjusted EBITDA for the three and six months ended June 30, 2024 has been revised to exclude the impact of scale up operating costs, as follows:

​ · ​ · ​ · ​ · ​ · ​ · ​
​​Three Months Ended​Six Months Ended
(Thousands) · June 30, 2024 · June 30, 2024
Consolidated Adjusted EBITDA, as presented​$13,664​$24,806
Conway extract and ready-to-drink facility scale-up costs​(1,230)​(1,230)
Consolidated Adjusted EBITDA, as revised​$12,434​$23,576
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.